Lilly(Eli) & Company

Filed a patent for "compounds and methods for liquid phase synthesis" on Thu, February 15, 2024

Filed a patent for "pd-1 agonist antibodies and methods of treating autoimmune diseases with a pd-1 agonist antibody" on Wed, February 21, 2024

Filed a patent for "(s)-3-((6-fluoropyridin-3-yl)methyl)-1-(5-(pyridin-4-yl)-4h-1,2,4-triazol-3-yl)piperidin-2-one benzenesulfonate" on Fri, August 25, 2023

Filed a patent for "needle system for drug delivery" on Thu, August 10, 2023

Filed a patent for "solid forms of a kv1.3 potassium shaker channel blockers and method of using the same" on Mon, July 31, 2023

Filed a patent for "gip/glp1 dual agonist therapeutic methods" on Tue, August 15, 2023

Filed a patent for "therapeutic uses and doses of lp(a) disrupter compounds" on Fri, June 30, 2023

Filed a patent for "antibody optimization" on Wed, January 31, 2024

Filed a patent for "methods and systems for detecting defects using topological persistence features" on Mon, June 12, 2023

Filed a patent for "optical sensing techniques for dose delivery" on Fri, June 16, 2023

Filed a patent for "nectin-4 antibodies and antibody-drug conjugates" on Tue, June 20, 2023

Filed a patent for "compounds for the delivery of granulin across the blood brain barrier" on Wed, June 21, 2023

Filed a patent for "formulations and dosing regimens for rip1 kinase inhibitors for treating autoimmune and inflammatory diseases" on Mon, June 26, 2023

Filed a patent for "sensor using electro-quasistatic human body communication" on Thu, December 15, 2022

Filed a patent for "techniques for analyzing non-compliant wearable device data" on Thu, December 15, 2022

Filed a patent for "methods of cleaning chromatography matrices" on Mon, December 19, 2022

Filed a patent for "methods of reducing contaminants in protein purification" on Mon, December 19, 2022

Filed a patent for "glp1 process" on Mon, December 19, 2022

Filed a patent for "novel rna therapeutics and uses thereof" on Wed, December 21, 2022

Filed a patent for "methods of reducing contaminants in protein purification" on Thu, December 22, 2022

Filed a patent for "oligonucleotide fragments and methods of making rnai agents using the same" on Thu, December 22, 2022

Filed a patent for "novel rna therapeutics and uses thereof" on Fri, December 23, 2022

Filed a patent for "novel rna therapeutics and uses thereof" on Fri, December 23, 2022

Filed a patent for "stabilization of lipid nanoparticle formulations" on Fri, December 23, 2022

Filed a patent for "processes and intermediates for preparing tirzepatide" on Thu, December 29, 2022